Every recall we track for GlaxoSmithKline LLC — 20 in all — plus the complaints and injury reports the public filed about them.
GlaxoSmithKline recalls ANORO ELLIPTA inhalers with failed release testing for coarse particle mass. This may affect inhaler safety and requires checking the NDC code and lot number.
GlaxoSmithKline recalls Tivicay 50mg tablets with incorrect expiration date labels (Jan 2027 instead of Sep 2026). This affects prescription bottles sold in the US. Check your label for lot number 2A9E.
